dactinomycin and Anaplastic Ependymoma

dactinomycin has been researched along with Anaplastic Ependymoma in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19905 (71.43)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bender, S; Jones, DT; Kool, M; Korshunov, A; Kulozik, AE; Lichter, P; Milde, T; Müller, S; Pajtler, KW; Peter Collins, V; Pfister, SM; Schlotter, M; Tzaridis, T; Witt, H; Witt, O; Wittmann, A1
DUKAT, EG; KJELLBERG, RN; MARK, VH; SOLOWAY, AH1
Li, ZY; Sun, L; Wan, Y; Xu, L; Yang, KX1
Kornblith, P; Weems, S; Wilkinson, HA1
Kauffman, W; Slagel, DE1
Kajiyama, T; Takahashi, T; Takaki, R; Takeno, Y; Takii, M1
Ahmann, DL; Cupps, RE; Soule, EH1

Other Studies

7 other study(ies) available for dactinomycin and Anaplastic Ependymoma

ArticleYear
Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymoma.
    Oncotarget, 2016, Sep-20, Volume: 7, Issue:38

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Dactinomycin; DNA Mutational Analysis; Ependymoma; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Immunohistochemistry; Medulloblastoma; Mice; Neurons; Piperazines; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-mdm2; Stem Cells; Transcription Factor RelA; Treatment Outcome; Tumor Suppressor Protein p53

2016
CHEMOTHERAPY OF BRAIN TUMORS. I. TRANSPLANTED MURINE EPENDYMOBLASTOMAS.
    Cancer chemotherapy reports, 1964, Volume: 36

    Topics: Alkylating Agents; Animals; Antineoplastic Agents; Brain Neoplasms; Cyclophosphamide; Dactinomycin; Ependymoma; Mannitol; Melphalan; Mice; Neoplasms; Neoplasms, Experimental; Neuroectodermal Tumors, Primitive; Pharmacology; Research; Toxicology

1964
[Ependymoma of ovary: report of a case].
    Zhonghua bing li xue za zhi = Chinese journal of pathology, 2007, Volume: 36, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cystadenocarcinoma, Papillary; Dactinomycin; Diagnosis, Differential; Ependymoma; Female; Follow-Up Studies; Glial Fibrillary Acidic Protein; Humans; Hysterectomy; Ovarian Neoplasms; Ovariectomy; Teratoma; Vimentin; Vincristine

2007
Focal chemotherapy of brain tumours using semipermeable membranes.
    Journal of neurology, neurosurgery, and psychiatry, 1977, Volume: 40, Issue:4

    Topics: Animals; Antineoplastic Agents; Bleomycin; Brain Neoplasms; Dactinomycin; Ependymoma; Fluorouracil; Glioma; Humans; In Vitro Techniques; Membranes, Artificial; Methods; Mice; Plicamycin; Thiotepa; Vincristine

1977
Murine primitive neuroectodermal tumor: nucleolar isolation and RNA polymerase inhibition.
    Experientia, 1979, May-15, Volume: 35, Issue:5

    Topics: Amanitins; Animals; Cell Fractionation; Cell Nucleolus; Cell Nucleus; Dactinomycin; DNA-Directed RNA Polymerases; Doxorubicin; Ependymoma; Magnesium; Mice; Neoplasms, Experimental; RNA Polymerase I

1979
Screening of carcinostatic agents in organ culture.
    Gan, 1968, Volume: 59, Issue:5

    Topics: Animals; Antibiotics, Antineoplastic; Carcinoma; Cerebellar Neoplasms; Chickens; Culture Techniques; Dactinomycin; DNA; DNA, Neoplasm; Ependymoma; Glioblastoma; Glioma; Humans; Mammary Neoplasms, Experimental; Meningioma; Mitomycins; Rats; Sarcoma; Scalp; Thymidine; Thymoma; Thymus Gland; Tritium

1968
Treatment of pulmonary metastatic disease with radiation therapy and adjuvant actinomycin D. Preliminary observations.
    Cancer, 1969, Volume: 24, Issue:4

    Topics: Adenocarcinoma; Adult; Carcinoma, Squamous Cell; Cobalt Isotopes; Dactinomycin; Ependymoma; Female; Fibrosarcoma; Hemangiopericytoma; Hemangiosarcoma; Humans; Infusions, Parenteral; Liposarcoma; Lung Neoplasms; Male; Mesenchymoma; Osteosarcoma; Radiotherapy Dosage; Radiotherapy, High-Energy; Retrospective Studies; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Sarcoma, Synovial; Teratoma

1969